Neural Account of Social Placebo Effect
1 other identifier
interventional
68
1 country
1
Brief Summary
The current study aimed to reveal the neural mechanism of social placebo belief formation and belief representation, and also investigated how the brain pattern predict the social behavior performance under placebo manipulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2018
CompletedFirst Submitted
Initial submission to the registry
March 17, 2019
CompletedFirst Posted
Study publicly available on registry
March 27, 2019
CompletedMarch 27, 2019
March 1, 2019
4 months
March 17, 2019
March 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The brain functional connectivity
For functional connectivity estimation, we adopted DLPFC, mPFC and reward related brain regions as the seeds to do whole-brain connectivity analysis. And the conducted two-sample T test to examine whether there would be some differences between spray+ and control groups.
8 mins, 240 TR in scanner
Social brain network properties in resting-state
For the network properties, we chose the social brain network as our target and interested network, then estimated the global efficiency within this network.And the conducted two-sample T test to examine whether there would be some differences between spray+ and control groups.
8 mins, 240 TR in scanner
The brain response pattern for the key concepts about oxytocin
We estimated the beta response trial by trial for each single concept and then investigated the neural representation of all concepts by using representational similarity analysis (RSA).
5.33mins, 160TR in scanner
Study Arms (2)
spray+ group
EXPERIMENTALIn spray+ condition, participants learned oxytocin materials on a self-paced basis and then intranasally administered with saline (but it was told as "oxytocin"). Participants were instructed to refrain from smoking or drinking (except water) for 2 h before the experiment. The spray was administered to each participant three times, and each administration consisted of one inhalation into each nostril. Participants took a rest (they were told it was a time period waiting for treatment to produce effects) for 10min and then performed the experimental tasks.
control group
PLACEBO COMPARATORIn control condition, the materials and procedure were same with the spray+ condition except the nasal spray was told as "saline" instead. Oxytocin materials used in current experiments were adopted from previous study
Interventions
Participants in spray+ group received placebo manipulation and were told they sprayed was oxytocin (in fact, it was saline);
Participants in control group were told they sprayed saline (in fact, it was saline).
Eligibility Criteria
You may qualify if:
- All participants had normal or corrected-to-normal vision, and mental healthy.
You may not qualify if:
- Participants who reported no history of neurological, endocrine or psychiatric disorders, who majored in psychology in college or recently participated in any other drug study were not recruited.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Normal University
Beijing, Beijing Municipality, 100000, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 17, 2019
First Posted
March 27, 2019
Study Start
June 27, 2018
Primary Completion
November 2, 2018
Study Completion
November 5, 2018
Last Updated
March 27, 2019
Record last verified: 2019-03